Brief Intervention and Contact Program Main Trial

Launched by ST. JOSEPH'S HEALTHCARE HAMILTON · Dec 12, 2022

Keywords

ClinConnect Summary

The Brief Intervention and Contact Program Main Trial is a research study aimed at reducing suicidal behavior among individuals who have recently attempted suicide or are experiencing suicidal thoughts. This trial is particularly important because studies have shown that patients are at a higher risk for further suicide attempts in the two years following their discharge from the hospital. The focus of the trial is to see if regular follow-up through text messages, phone calls, and letters can help reduce these risks and provide support during a vulnerable time.

To be eligible for this study, participants must be at least 16 years old and have been admitted to the hospital due to suicidal behavior. They need to provide consent for the research team to access their medical records and communicate with their healthcare providers. If you join the study, you can expect to receive regular contact and support from the research team, which may help you feel less isolated and more supported after your hospital stay. It's important to note that this trial is currently recruiting participants who can understand English, as the intervention will be delivered in that language.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Admitted following a suicidal behaviour (suicide attempt or with suicidal ideation),
• • At least 16 years of age, no restrictions on sex or gender
• • Provide written, informed consent,
• • Provide consent for research staff to have access to their electronic medical record (EMR),
• • Provide consent for research staff to contact their primary care provider, outpatient and other healthcare providers care team, if necessary,
• • Provide health card number and consent to share with Institute for Clinical Evaluative Sciences and link to Ontario health records to analyze and evaluate events such as admissions, death by suicide and usage of health care services (such as hospitalizations) in Ontario for the period covering the study time and 2 years post study completion. The 2 years post discharge will not be feasible to continue follow up for this trial and are reported to be a risk period in the literature. Therefore, we opted to leverage administrative health record data to enrich the study impact post study completion.
• • Exclusion criteria
• • - We will exclude patients who are unable to understand written and spoken English, as the research staff/clinicians delivering the intervention are limited to English-speaking populations.

Trial Officials